Russia's Gamaleya Center adapts Sputnik V to fight Delta, Omicron variants
The Gamaleya Research Institute of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF) have announced the development of another version of the Sputnik V coronavirus vaccine, tailored to combat the Delta and Omicron …